Nomura Asset Management International’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Buy
20,000
+716
+4% +$37K ﹤0.01% 1152
2026
Q1
$980K Sell
19,284
-716
-4% -$33.4K ﹤0.01% 1117
2025
Q4
$590K Buy
+20,000
New +$543K ﹤0.01% 1156

Other funds holding MRNA

Nomura Asset Management International's MRNA Position: Q2 2026 in Review

Nomura Asset Management International increased its Moderna (MRNA) stake by 3.7% in Q2 2026, buying an estimated $37K and bringing the position to 20,000 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

Nomura Asset Management International first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Nomura Asset Management International held 20,000 shares of Moderna worth $1.4M as of Q2 2026.
  • Nomura Asset Management International bought 716 Moderna shares in Q2 2026, an estimated $37K.
  • Moderna made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1152 holding.
  • Nomura Asset Management International first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.